Wound care company Choice Therapeutics Inc. has sold $582,000 of a planned $3 million equity round.
WRENTHAM, MA, Wound care company Choice Therapeutics Inc. has sold $582,000 of a planned $3 million equity round, according to filings with the SEC.
Choice Therapeutics develops, manufactures and commercializes innovative medical devices targeted at three major markets - burns, advanced wound care, and surgical site infections.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
